3i Deutschland
3i Group plc
3i Schweiz
ABMI SA
ABN AMRO Capital
Accelsiors Group International
Ace BioSciences
Adamant Biomedical Investments
Addex Pharmaceuticals SA
Affibody AB
Affimed Therapeutics AG
Algeta
Alice Ventures
Alizyme
Alta Partners
Amafin Asset Management & Finance
American Heritage Fund
Amt für Wirtschaft und Arbeit
Anergis
Antisoma Research Ltd
Apax Partners
Aponetics
Apoxis SA
Aravis Partners
Ark Therapeutics Plc
Arpida
Artemis Pharmaceuticals
AstraZeneca
Athelas SA
Atlas Venture
Atugen AG
Austrianova Biotechnology
Aventic Partners AG
Avidex
AXA Private Equity
AXA Venture Fund
Bank Julius Baer
Bank Leu
Bank Sarasin & Cie AG
Bank von Ernst & Cie AG
Bank Vontobel AG
BayTech Venture Capital
BB Biotech
Bio Delivery System
BioAlps
BioConnect AG
Bioenvision
BioExec Ventures, LLC
Biogen Idec
Bio-M AG
Biomedinvest AG
Biomedinvestor AG
biomedpark m.e.d.i.e.n GmbH
Biopolo Ticino
BioPro Baden-Württemberg GmbH
BioScience Managers Ltd
Biotech Center Zurich
Biotechnology Investment Today
BioTie Therapies Corporation
BioValley-Basel Area
Biovex
BioXell
Bloomberg
Boehringer Ingelheim
Boerse Online
Bollinger Consulting
Bosch, Graf v Stosch, Jehle
Buegler Investment Research
Bund Capital, Ltd.
Business Wire
Canadian Consulate General
Capital Dynamics
Cardiokine Inc
CareX SA
CDC Enterprises Innovation
Chroma Therapeutics Limited
Clariden Bank
Coller Capital
Combinature Biopharm
Credit Suisse
Credit Suisse Asset Management
Credit Suisse First Boston
Credit Suisse Private Banking
Crucell N.V
Curevac
Cyberkinetics
Cyclacel
Cyprotex
Cytheris SA
Cytos Biotechnology
De Novo Pharmaceuticals
Deutsche Ban
Deutsche Börse AG
Deutsche Venture Capital
DeveloGen AG
DIREVO Biotech AG
Dow Jones Newswires
DyoDelta Biosciences Ltd
Earlybird GmbH & Co.
Elchrom Scientific
Eli Lilly and Company
Epigenomics
EPS Value Plus
ErfindungsVerwertung
Erimos Pharmaceuticals Ltd
Ernst & Young Corporate Finance Beratung
ESBATech AG
European Technology Ventures
Evotec OAI AG
F.Hoffman – La Roche
Fairvest AG
Finanz und Wirtschaft
Ganymed Pharmaceuticals
Gena
General Research GmbH
Generex Biotechnology
GENETIX Pharmaceuticals, Inc
Genetronics
Genetronics Biomedical Corp.
Genevest
Genzyme
GGA Software
Gilde Investment Management
GIMV
Global Genomics
Global Life Science Ventures AG
GLYCART Biotechnology AG
Glycogenesys Inc
Greater Zurich Area
Grupo Uriach
HBM Partners AG
Helsinn Healthcare SA
HHC Healthcare
Highide Capital Management
HSBC Guyerzeller Bank
Hybrigenics
HypoVereinsbank
IBFB Pharma GmbH
IBM (UK) Ltd
Icon Genetics
Iconix Pharmaceuticals Inc
IC-Vec Ltd
Index Ventures
Immatics Biotechnology GmbH
Independent Consultant
Infineon Technologies AG
Innovationskapital
Inproteo, LLC
Institute of Brain Research
IntegraGen SA
Intercell AG
International Journal of Medical Marketing
International Pharma Consulting
Investment Consulting
iSIMA Private Equity Ltd
IsoTis
ITX Corporation
Jefferies & Co.
Julius Baer Asset Management
Katan Associates
Kepler Equities
Kirchhoff Consult (Shweiz) AG
Kuros Biosurgery AG
Laboratoires Fournier S.A.
Landesbank Baden-Wurtemburgg
Lehman Brothers
Life Point
Life Sciences Partners
Lombard Odier Darier Hentsch & Cie
Lonza Group Ltd
Lunmaed
MacroPore Biosurgery Inc
MedVenture Partners GmbH
Merck KGaA
Merck Sharp & Dohme-Chibret
Microscience Ltd
Molecular Network GmbH
mondoBiotech Group
Morgan Lewis
MPM Capital GmbH
Mulligan BioCapital AG
MWG Biotech AG
Nature Publishing Group
Nautilus Biotech
Nemed Management
Neovacs
Neuraxo Biotech GmbH
Neuro3d
Newron Pharmaceuticals
Nextech Venture
NIG
Nomura International plc
Nomura Phase4 Ventures
Northbank Communications
Novartis Pharmaceuticals Corporation
Novartis Venture Fund
Novo A/S
Nuevolution A/S
Oncore Therapeutics
Onco XL
Onyvax Ltd
Perseus-Soros BioPharmaceutical Fund
Pictet & Cie
Pieris Proteolab AG
Polaris Venutre Partners
PolyTechnos Venture-Partners GmbH
Pricewaterhouse Coopers Corporate Finance
Prionics
Privateq Adcisors
Procyon Biopharma Inc
Prosolia, Inc
Puerto Rico Commercial Office in Europe
Rennes Roundation
Response Biomedical Corporation
Rochat & Partners
Roche
SAM-Sustainable Asset Management
Sandoz GmbH
Sanochemia Pharmazeutika AG
ScanCell
Schroders
Schwarz Financial Communication
Scottish Equity Partners
SEED Venture GmbH
Serono International
Shire Pharmaceuticals Group Plc
SIRENADE Pharmaceuticals AG
SJ Berwin
Skandia Life Asset Management
Sofinnova
Speedel Group
Speedel Holding
SPEF VENTURE
Stabford University/Equity4Health
SUD VENTURE CAPITAL GMBH
swissfirst Bank AG
Swiss Federal Institute of Technology
SWX Swiss Exchange
Syngenta
Tahoe Invest
TGE Corp.
Tapestry Pharmaceuticals
Techno Venture Management GmbH (TVM)
TeGenero AG
The BioScience Ventures Group
The Genetics Company
TheraSTrat AG
Thiakis Limited
Trigen Ltd
UBS Asset Management
UBS Investment Bank
Ultreia Capital
Unitectra
Venture Valuation Inc
Vernalis
VIA Pharmaceuticals Inc
VI Partners AG
Warburg Pincus International
Wellington Partners Venture Capital GmbH
Wilshire Associates Europe
Xantos Biomedicine
Xigen SA
XYTIS Pharmaceuticals Ltd.
YM Biosciences
Zealand Pharma
Zonagen
Zurich MedNet, Greater Zurich Area